Castle Hook Partners’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-36,253
Closed -$1.44M 66
2021
Q4
$1.44M Sell
36,253
-38,347
-51% -$1.75M 0.06% 60
2021
Q3
$3.73M Buy
+74,600
New +$4.07M 0.14% 46

Other funds holding HCAT

Castle Hook Partners's HCAT Position: Q1 2022 in Review

Castle Hook Partners sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 36,253 shares — an estimated $1.44M sold.

Castle Hook Partners first reported a position in HCAT in Q3 2021 and held it in 2 quarters. The position peaked at $3.73M in Q3 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Castle Hook Partners reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Castle Hook Partners sold 36,253 Health Catalyst shares in Q1 2022, an estimated $1.44M.
  • Castle Hook Partners first reported a position in Health Catalyst in Q3 2021 and held it in 2 quarters.
  • Castle Hook Partners's Health Catalyst position peaked at $3.73M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Castle Hook Partners's 13F filing for Q1 2022, filed 13 May 2022.